Search
Skip to Search Results
Filter
Subject / Keyword
- 12Chronic Myeloid Leukemia
- 11BCR-ABL
- 10Chronic Myelogenous Leukemia
- 10Hematology
- 10Philadelphia Chromosome
- 10Romanowsky Stain
Author / Creator / Contributor
Year
Collections
Languages
-
Safe Polymeric Nucleic Acid Delivery Systems for Cancer Therapy: Focus on Breast Cancer and Chronic Myeloid Leukemia
DownloadFall 2021
Meenakshi Sundaram, Daniel Nisakar
RNA interference (RNAi) is a promising technology to specifically target the upregulated genes that provide uncontrolled proliferation and survival of cancers. The target specific silencing is accomplished by the delivery of small interfering RNA (siRNA), which require safe delivery systems to...
-
Spring 2017
BCR-ABL fusion oncogene is the main driver mutation of Chronic Myeloid Leukemia (CML) that controls initiation, maintenance and progression to more aggressive stages of the disease. Current therapies with tyrosine kinase inhibitors in CML involve certain limitations, such as drug resistance and...
11 - 12 of 12